1-3 of 3
David B. Goldstein
Close
Sort by
Journal Articles

Exome Sequencing Studies Identify Mutations in STAB2 As a Genetic Risk for Venous Thromboembolic Disease

Karl Desch, MD, Ayse Bilge Ozel, PhD, Matthew Halvorsen, PhD, Alison L. Michels, Laura L Swystun, BSc, PhD, Lauren Mokry, PhD, Brent Richards, Marine Germain, David A. Tregouet, PhD, Pieter H. Reitsma, PhD, Clive Kearon, MB, Jun Z Li, PhD, David B. Goldstein, PhD, David Lillicrap, MD FRCPC, David Ginsburg, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 457.
https://doi.org/10.1182/blood.V130.Suppl_1.457.457
Published: 2017
Journal Articles

Genome-Wide Association Study of the Human Genetic Factors Influencing the Risk of Adverse Events during Idelalislib Therapy in Patients with Relapsed Indolent Lymphoma

Patrick R. Shea, David B. Goldstein, Veerendra Munugalavadla, Lyndah K. Dreiling, Sarah E. Kleinstein, Wojciech Jurczak, Ian W. Flinn, MD PhD, Gilles A. Salles
Journal: Blood
Blood (2016) 128 (22): 5284.
https://doi.org/10.1182/blood.V128.22.5284.5284
Published: 2016
Journal Articles

A nonsense mutation in IKBKB causes combined immunodeficiency

Brief Report
Talal Mousallem, Jialong Yang, Thomas J. Urban, Hongxia Wang, Mehdi Adeli, Roberta E. Parrott, Joseph L. Roberts, David B. Goldstein, Rebecca H. Buckley, Xiao-Ping Zhong
Journal: Blood
Blood (2014) 124 (13): 2046–2050.
https://doi.org/10.1182/blood-2014-04-571265
Published: 2014
Includes: Supplemental data